I think the overall interest in CYDY at this point is a huge factor. It has always seemed odd to me that media discussions have hardly mentioned Leronlimab, and maybe there are biases in many of their comments and interests, but clearly the share price and volume and # of stock holders has proven that Leronlimab and CYDY are known. By many. And certainly some with large deep pockets. Once the announcement of M2M results is made, and obviously presuming they are as fantastic as we just know they will be, the share should have a dramatic jump. And then other catalysts continue to kick in, more big investors continue to jump in, and it just snowballs. That's the way I'm seeing it now. As a long-time investor, the anticipation of THIS WEEK is most exciting. And it's getting harder to wait, but all I can add is...
To The Moon Alice